Your browser doesn't support javascript.
loading
Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer.
Heerma van Voss, Marise R; Brilliant, Justin D; Vesuna, Farhad; Bol, Guus M; van der Wall, Elsken; van Diest, Paul J; Raman, Venu.
Afiliação
  • Heerma van Voss MR; Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD, 21205, USA.
  • Brilliant JD; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Vesuna F; Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD, 21205, USA.
  • Bol GM; Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD, 21205, USA.
  • van der Wall E; Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD, 21205, USA.
  • van Diest PJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Raman V; Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Med Oncol ; 34(3): 33, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28138868

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / RNA Helicases DEAD-box Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / RNA Helicases DEAD-box Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article